Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -40.47% is 16% below its 5-year average of -34.74%, near the low end of its 5-year range (-51.89%–-4.56%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.80% above its 12-month average of -42.06%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -40.47%.
RETURN ON INVESTED CAPITAL (ROIC)
-40.47%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-42.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-40.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-34.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+3.80%
CURRENT VS 3Y AVG
+0.42%
CURRENT VS 5Y AVG
-16.49%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-29.43%
median of 512 covered companies
CURRENT VS SECTOR MEDIAN
-37.52%
vs the sector median at left
Alpha Tau Medical Ltd
Market Cap
$1.36B
Return on Invested Capital (ROIC)
-40.47%
TTM Avg
-42.06%
3Y Avg
-40.64%
5Y Avg
-34.74%
Market Cap
$1.38B
Return on Invested Capital (ROIC)
-38.09%
TTM Avg
-38.09%
3Y Avg
-38.09%
5Y Avg
-38.09%
Market Cap
$1.33B
Return on Invested Capital (ROIC)
-47.96%
TTM Avg
-47.20%
3Y Avg
-41.20%
5Y Avg
-37.18%
Market Cap
$1.40B
Return on Invested Capital (ROIC)
-24.52%
TTM Avg
-24.52%
3Y Avg
-24.52%
5Y Avg
-24.52%
Market Cap
$1.40B
Return on Invested Capital (ROIC)
-99.35%
TTM Avg
-175.72%
3Y Avg
-121.81%
5Y Avg
-100.94%
Market Cap
$1.29B
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-57.11%
3Y Avg
-57.11%
5Y Avg
-57.11%
Market Cap
$1.43B
Return on Invested Capital (ROIC)
47.55%
TTM Avg
-5.71%
3Y Avg
-17.68%
5Y Avg
-14.30%
Market Cap
$1.47B
Return on Invested Capital (ROIC)
16.83%
TTM Avg
6.43%
3Y Avg
6.32%
5Y Avg
5.53%
Market Cap
$1.24B
Return on Invested Capital (ROIC)
-52.44%
TTM Avg
-96.82%
3Y Avg
-100.85%
5Y Avg
-77.97%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Tau Medical Ltd (DRTS) | $1.36B | -40.47% | -42.06% | -40.64% | -34.74% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.38B | -38.09% | -38.09% | -38.09% | -38.09% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $1.33B | -47.96% | -47.20% | -41.20% | -37.18% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | -24.52% | -24.52% | -24.52% | -24.52% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.40B | -99.35% | -175.72% | -121.81% | -100.94% |
| Kardigan, Inc. (KARD)vs › | $1.29B | -57.11% | -57.11% | -57.11% | -57.11% |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 47.55% | -5.71% | -17.68% | -14.30% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.47B | 16.83% | 6.43% | 6.32% | 5.53% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.24B | -52.44% | -96.82% | -100.85% | -77.97% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.48B | N/A | N/A | N/A | N/A |
ROIC
-40.5%
ROE
-210.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -40.47% |
| 2026-03-31 | -47.08% |
| 2025-12-31 | -44.45% |
| 2025-09-30 | -41.82% |
| 2025-06-30 | -36.50% |
| 2025-03-31 | -51.89% |
| 2024-12-31 | -46.49% |
| 2024-09-30 | -42.32% |
| 2024-06-30 | -40.57% |
| 2024-03-31 | -37.15% |
| 2023-12-31 | -35.58% |
| 2023-09-30 | -33.55% |
| 2023-06-30 | -30.40% |
| 2023-03-31 | -28.90% |
| 2022-12-31 | -27.75% |
| 2022-09-30 | -21.80% |
| 2022-06-30 | -17.79% |
| 2022-03-31 | -15.11% |
| 2021-12-31 | -29.06% |
| 2021-09-30 | -4.56% |
| 2021-06-30 | -26.06% |
| 2021-03-31 | -3.64% |
| 2020-12-31 | -18.16% |
| 2020-09-30 | -16.76% |
| 2020-06-30 | -61.48% |
| 2020-03-31 | -62.21% |
| 2019-12-31 | -106.06% |
